Hyperglycaemia Signs and Symptoms Elevated blood glucose level
Conditions
Interventions
The project is based in the Universidad Católica de Chile Hospital, which is the main private facility of the Pontificia Universidad Católica de Chile, in Santiago, Chile. The clinical team in charge
Sponsors
National Fund of Investigation and Development in Health (Fondo nacional de investigación y desarrollo en salud [FONIS]) (Chile)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult inpatients (aged greater than 18 years, men and women) with an acute medical or surgical condition, and any of the following criteria: 1. In subjects known to have diabetes: Capillary blood glucose level over 180 mg/dl, in consecutive measurements separated by 2 hours, or just one measurement if insulin was administered after the first 2. In subjects without previous diagnosis of diabetes: Capillary blood glucose level over 200 mg/dl in consecutive measurements separated by 2 hours, or just one measurement if insulin was administered after the first
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Acute complications of diabetes 3. Terminal illness (expected survival of less than a month) 4. Elective hospitalisation 5. Hospitalisation stay predicted to last less than 72 hours 6. Haemodyalisis initiated during hospitalisation 7. Peritoneal dialysis 8. Corticosteroids (prednisone) dose over 30 mg/day 9. Parenteral nutrition 10. Inability to receive carbohydrates by mouth for more than 8 hours 11. Patients with an unresolved surgical condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of measurements of blood glucose levels between 70 and 130 mg/dl. All measurements will be recorded at day 7 and at the moment of discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mean blood glucose level 2. Length of hospitalisation 3. Healthcare-associated infections 4. Number of measurements of blood glucose levels below 70 mg/dl 5. Time to achieve good glycaemic control (two or more measurements between 70 and 130 mg%) All measurements will be recorded at day 7 and at the moment of discharge. | — |
Countries
Chile
Outcome results
None listed